Annual Net Margin
N/A
31 December 2022
Summary:
Nymox Pharmaceutical annual net profit margin is not available.NYMX Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Net Margin
N/A
31 March 2023
Summary:
Nymox Pharmaceutical quarterly net profit margin is not available.NYMX Quarterly Net Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
NYMX Net Margin Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
NYMX Net Margin High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time |
Nymox Pharmaceutical Net Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | -234.76 K%(+1969.0%) | - |
| Mar 2020 | - | -52.30 K%(+406.1%) |
| Dec 2019 | -11.35 K%(+220.2%) | -10.33 K%(+63.8%) |
| Sept 2019 | - | -6310.26%(-75.5%) |
| June 2019 | - | -25.72 K%(+168.9%) |
| Mar 2019 | - | -9566.67%(-33.2%) |
| Dec 2018 | -3543.14%(-40.9%) | -14.32 K%(+105.2%) |
| Sept 2018 | - | -6977.50%(+153.8%) |
| June 2018 | - | -2748.86%(+56.8%) |
| Mar 2018 | - | -1752.63%(-44.7%) |
| Dec 2017 | -5995.09%(+29.9%) | -3169.52%(-78.6%) |
| Sept 2017 | - | -14.78 K%(-50.8%) |
| June 2017 | - | -30.06 K%(+733.1%) |
| Mar 2017 | - | -3607.69%(-48.1%) |
| Dec 2016 | -4616.20%(+612.5%) | -6952.86%(+15.6%) |
| Sept 2016 | - | -6012.20%(+135.4%) |
| June 2016 | - | -2554.26%(-68.1%) |
| Mar 2016 | - | -8012.48%(+46.8%) |
| Dec 2015 | -647.86%(+315.9%) | -5456.95%(-74.4%) |
| Sept 2015 | - | -21.36 K%(+122.9%) |
| June 2015 | - | -9582.99%(<-9900.0%) |
| Mar 2015 | - | 61.01%(-190.3%) |
| Dec 2014 | -155.76%(+6.6%) | -67.59%(-27.8%) |
| Sept 2014 | - | -93.57%(-14.2%) |
| June 2014 | - | -109.04%(-69.2%) |
| Mar 2014 | - | -353.94%(+152.0%) |
| Dec 2013 | -146.13%(-41.1%) | -140.47%(+2.3%) |
| Sept 2013 | - | -137.28%(-22.0%) |
| June 2013 | - | -175.97%(+34.9%) |
| Mar 2013 | - | -130.44%(-63.4%) |
| Dec 2012 | -248.25%(-19.9%) | -356.40%(+118.8%) |
| Sept 2012 | - | -162.91%(-26.3%) |
| June 2012 | - | -220.97%(-11.5%) |
| Mar 2012 | - | -249.73%(+17.0%) |
| Dec 2011 | -309.99%(-67.2%) | -213.36%(+6.4%) |
| Sept 2011 | - | -200.57%(-21.1%) |
| June 2011 | - | -254.17%(-56.1%) |
| Mar 2011 | - | -579.22%(-11.8%) |
| Dec 2010 | -945.31%(-23.3%) | -656.99%(-89.3%) |
| Sept 2010 | - | -6131.25%(+289.3%) |
| June 2010 | - | -1574.93%(+228.5%) |
| Mar 2010 | - | -479.36%(-48.0%) |
| Dec 2009 | -1233.25%(+13.9%) | -921.04%(-51.4%) |
| Sept 2009 | - | -1895.36%(+24.8%) |
| June 2009 | - | -1518.72%(+45.5%) |
| Mar 2009 | - | -1043.65%(+36.5%) |
| Dec 2008 | -1082.40% | -764.31%(-53.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2008 | - | -1639.86%(+73.8%) |
| June 2008 | - | -943.45%(-19.2%) |
| Mar 2008 | - | -1167.60%(+23.1%) |
| Dec 2007 | -1219.18%(+10.3%) | -948.76%(-51.9%) |
| Sept 2007 | - | -1973.76%(+17.8%) |
| June 2007 | - | -1675.92%(+105.2%) |
| Mar 2007 | - | -816.73%(-44.1%) |
| Dec 2006 | -1105.02%(+31.4%) | -1460.32%(+67.2%) |
| Sept 2006 | - | -873.54%(-22.7%) |
| June 2006 | - | -1130.46%(+2.5%) |
| Mar 2006 | - | -1103.27%(+43.1%) |
| Dec 2005 | -840.88%(-27.7%) | -771.07%(-18.9%) |
| Sept 2005 | - | -951.26%(+31.4%) |
| June 2005 | - | -723.77%(-23.0%) |
| Mar 2005 | - | -939.53%(-22.0%) |
| Dec 2004 | -1163.43%(-46.5%) | -1204.73%(+77.4%) |
| Sept 2004 | - | -679.23%(-50.7%) |
| June 2004 | - | -1376.57%(-16.8%) |
| Mar 2004 | - | -1654.42%(-63.5%) |
| Dec 2003 | -2175.71%(+130.0%) | -4533.65%(+212.6%) |
| Sept 2003 | - | -1450.23%(-2.2%) |
| June 2003 | - | -1483.38%(-45.6%) |
| Mar 2003 | - | -2728.69%(+55.0%) |
| Dec 2002 | -945.97%(-27.0%) | -1760.79%(+58.1%) |
| Sept 2002 | - | -1113.54%(+128.3%) |
| June 2002 | - | -487.74%(-65.6%) |
| Mar 2002 | - | -1417.26%(+273.7%) |
| Dec 2001 | -1296.07%(-49.2%) | - |
| Sept 2001 | - | -379.22%(-18.9%) |
| June 2001 | - | -467.41%(-47.4%) |
| Mar 2001 | - | -888.11%(-70.0%) |
| Dec 2000 | -2551.86%(+18.0%) | -2960.71%(+60.5%) |
| Sept 2000 | - | -1844.21%(-48.3%) |
| June 2000 | - | -3564.28%(+72.2%) |
| Mar 2000 | - | -2070.25%(+20.5%) |
| Dec 1999 | -2162.64%(+23.7%) | -1717.96%(+114.7%) |
| Sept 1999 | - | -800.00%(+60.0%) |
| June 1999 | - | -500.00%(-70.5%) |
| Mar 1999 | - | -1693.22%(+113.4%) |
| Dec 1998 | -1748.47%(-91.5%) | -793.28%(-33.9%) |
| Sept 1998 | - | -1200.00%(+9.1%) |
| June 1998 | - | -1100.00%(-15.4%) |
| Mar 1998 | - | -1300.00%(+30.0%) |
| Dec 1997 | -20.55 K% | - |
| Sept 1997 | - | -1000.01%(+11.1%) |
| June 1997 | - | -900.01%(+12.5%) |
| Mar 1997 | - | -800.00% |
FAQ
- What is the all time high annual net margin for Nymox Pharmaceutical?
- What is the all time high quarterly net margin for Nymox Pharmaceutical?
What is the all time high annual net margin for Nymox Pharmaceutical?
Nymox Pharmaceutical all-time high annual net profit margin is -146.13%
What is the all time high quarterly net margin for Nymox Pharmaceutical?
Nymox Pharmaceutical all-time high quarterly net profit margin is 61.01%